Park YH - Search Results

1

The Pattern of Care for Brain Metastasis from Breast Cancer over the Past 10 Years in Korea: A Multicenter Retrospective Study (KROG 16-12).

Kim JS, Kim K, Jung W, Shin KH, Im SA, Kim HJ, Kim YB, Chang JS, Kim JH, Choi DH, Park YH, Kim DY, Kim TH, Choi BO, Lee SW, Kim S, Kwon J, Kang KM, Chung WK, Kim KS, Nam JH, Yoon WS, Kim JH, Cha J, Oh YK, Kim IA. Kim JS, et al. Among authors: park yh. Cancer Res Treat. 2022 Oct;54(4):1121-1129. doi: 10.4143/crt.2021.1083. Epub 2021 Dec 31. Cancer Res Treat. 2022. PMID: 34990524 Free PMC article.

2

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.

Kim TM, Park YH, Lee SY, Kim JH, Kim DW, Im SA, Kim TY, Kim CW, Heo DS, Bang YJ, Chang KH, Kim NK. Kim TM, et al. Among authors: park yh. Blood. 2005 Dec 1;106(12):3785-90. doi: 10.1182/blood-2005-05-2056. Epub 2005 Aug 18. Blood. 2005. PMID: 16109779 Free article.

3

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.

Lee KS, Chung HC, Im SA, Park YH, Kim CS, Kim SB, Rha SY, Lee MY, Ro J. Lee KS, et al. Among authors: park yh. Breast Cancer Res Treat. 2008 Mar;108(2):241-50. doi: 10.1007/s10549-007-9591-y. Epub 2007 May 3. Breast Cancer Res Treat. 2008. PMID: 17476588 Clinical Trial.

4

High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.

Park SC, Jeong SH, Kim J, Han CJ, Kim YC, Choi KS, Cho JH, Lee M, Jung HH, Ki SS, Chang YH, Lee SS, Park YH, Lee KH. Park SC, et al. Among authors: park yh. J Med Virol. 2008 Jun;80(6):960-6. doi: 10.1002/jmv.21168. J Med Virol. 2008. PMID: 18428141

5

Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes?

Park BB, Uhm JE, Cho EY, Choi YL, Ji SH, Nam DH, Lee JI, Park W, Huh SJ, Park YH, Ahn JS, Im YH. Park BB, et al. Among authors: park yh, park w. Cancer Chemother Pharmacol. 2009 Mar;63(4):627-33. doi: 10.1007/s00280-008-0779-6. Epub 2008 Jun 14. Cancer Chemother Pharmacol. 2009. PMID: 18553084

6

Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy.

Uhm JE, Park YH, Yi SY, Cho EY, Choi YL, Lee SJ, Park MJ, Lee SH, Jun HJ, Ahn JS, Kang WK, Park K, Im YH. Uhm JE, et al. Among authors: park yh, park mj, park k. Int J Cancer. 2009 Mar 15;124(6):1457-62. doi: 10.1002/ijc.24090. Int J Cancer. 2009. PMID: 19065658 Free article.

7

Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer.

Kim HS, Park YH, Park MJ, Chang MH, Jun HJ, Kim KH, Ahn JS, Kang WK, Park K, Im YH. Kim HS, et al. Among authors: park yh, park mj, park k. Breast Cancer Res Treat. 2009 Nov;118(1):89-97. doi: 10.1007/s10549-009-0377-2. Epub 2009 Mar 26. Breast Cancer Res Treat. 2009. PMID: 19322651

8

Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?

Kim KH, Lee J, Lee JI, Nam DH, Kong DS, Ahn YC, Park HC, Kwon OJ, Kim H, Chang MH, Yi SY, Ji SH, Park YH, Ahn JS, Park K, Ahn MJ. Kim KH, et al. Among authors: park yh, park hc, park k. Lung Cancer. 2010 May;68(2):258-63. doi: 10.1016/j.lungcan.2009.06.008. Epub 2009 Jul 9. Lung Cancer. 2010. PMID: 19592127

9

Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.

Park YH, Lee S, Cho EY, Choi YL, Lee JE, Nam SJ, Yang JH, Ahn JS, Im YH. Park YH, et al. Cancer Chemother Pharmacol. 2010 Aug;66(3):507-16. doi: 10.1007/s00280-009-1190-7. Epub 2009 Dec 3. Cancer Chemother Pharmacol. 2010. PMID: 19956951

10

A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?

Park YH, Kim ST, Cho EY, Choi YL, Ok ON, Baek HJ, Lee JE, Nam SJ, Yang JH, Park W, Choi DH, Huh SJ, Ahn JS, Im YH. Park YH, et al. Among authors: park w. Breast Cancer Res Treat. 2010 Feb;119(3):653-61. doi: 10.1007/s10549-009-0665-x. Breast Cancer Res Treat. 2010. PMID: 19957028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,004 results

Search Page